Johnson & Johnson
Market Cap
$585.82B
P/E Ratio
22.02
EPS
$11.04
Dividend Yield
2.16%
52-Week Range
$141.50 — $251.71
Volume
2.61M
Avg Volume
8.80M
Beta
0.33
P/E (TTM)
22.02
Forward P/E
21.02
PEG Ratio
3.39
P/S (TTM)
6.15
P/B (TTM)
7.16
P/FCF
0.00
EV/EBITDA
0.00x
EV/Sales
—
ROE (TTM)
0.34%
ROA (TTM)
0.13%
ROIC
0.00%
Gross Margin
0.73%
Operating Margin
0.27%
Net Margin
0.21%
Debt/Equity
0.59
Current Ratio
1.03
EPS Growth (YoY)
+0.48%
Revenue Growth (YoY)
+0.08%
EPS Growth (3Y)
+0.45%
EPS Growth (5Y)
+0.32%
Sales Growth (3Y)
+0.06%
Sales Growth (5Y)
+0.03%
EPS Est (This Year)
$11.57
EPS Est (Next Year)
$12.54
Dividend Yield
—
Annual Dividend
$1.30
Payout Ratio
0.62%
Frequency
—
Ex-Dividend Date
2025-11-25
Cash/Share
$8.28
Strong Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $229.33(-5.7% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
2.41B
Float
2.41B
Free Float %
99.87%
RSI (14)
90.67
SMA 20
$226.33
SMA 50
$214.52
SMA 200
$187.02
ATR (14)
3.62
Volatility (Week)
0.01%
Volatility (Month)
0.01%
Pattern
—
1 Day
-0.12%
1 Week
+2.25%
1 Month
+16.62%
3 Months
+27.75%
6 Months
+37.12%
1 Year
—
YTD
+14.95%
All-Time High
$240.94
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
US
Exchange
NYSE
IPO Date
1943-01-02
Employees
138100
CEO
Joaquin Duato
Index Membership
Dow Jones, S&P 500
Website
https://www.jnj.com
Johnson & Johnson (JNJ) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $585.82B, a P/E ratio of 22.02, and a dividend yield of 2.16%, JNJ is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare JNJ against other stocks using dozens of fundamental and technical filters.
Johnson & Johnson (JNJ) has a trailing twelve-month (TTM) P/E ratio of 22.02. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Johnson & Johnson (JNJ) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Johnson & Johnson (JNJ) has a market capitalization of $585.82 billion, classifying it as a mega-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Strong Buy" rating on Johnson & Johnson (JNJ) with an average score of 1.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $229.33 implies 5.7% downside from the current price.
Johnson & Johnson (JNJ) has returned +14.95% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.